Arrowhead Pharmaceuticals, Inc. (ARWR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.50B |
| Enterprise value | 3.10B |
| Trailing P/E | 478.56 |
| Forward P/E | 111.11 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 88.41 |
| Price/book (mrq) | 7.24 |
| Enterprise value/revenue | 87.34 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.94 |
| 52-week change 3 | -18.34% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 39.83 |
| 52-week low 3 | 20.67 |
| 50-day moving average 3 | 25.90 |
| 200-day moving average 3 | 27.72 |
Share statistics
| Avg vol (3-month) 3 | 1.06M |
| Avg vol (10-day) 3 | 923.26k |
| Shares outstanding 5 | 124.2M |
| Implied shares outstanding 6 | 124.2M |
| Float 8 | 110.69M |
| % held by insiders 1 | 4.47% |
| % held by institutions 1 | 78.90% |
| Shares short (15 Jul 2024) 4 | 9.04M |
| Short ratio (15 Jul 2024) 4 | 8.17 |
| Short % of float (15 Jul 2024) 4 | 8.54% |
| Short % of shares outstanding (15 Jul 2024) 4 | 7.28% |
| Shares short (prior month 14 Jun 2024) 4 | 9.45M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 17 Nov 2011 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Sept 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,335.58% |
Management effectiveness
| Return on assets (ttm) | -32.07% |
| Return on equity (ttm) | -99.43% |
Income statement
| Revenue (ttm) | 35.47M |
| Revenue per share (ttm) | 0.32 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -457.85M |
| Net income avi to common (ttm) | -470.79M |
| Diluted EPS (ttm) | -4.23 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 520.91M |
| Total cash per share (mrq) | 4.19 |
| Total debt (mrq) | 399.86M |
| Total debt/equity (mrq) | 80.71% |
| Current ratio (mrq) | 8.31 |
| Book value per share (mrq) | 3.90 |
Cash flow statement
| Operating cash flow (ttm) | -256.92M |
| Levered free cash flow (ttm) | -383.73M |
© 2024 Yahoo. All rights reserved.